- Home
- PPC vs RGC Comparison
PPC vs RGC Comparison
Compare PPC & RGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PPC | RGC |
|---|---|---|
| Founded | 1946 | 2014 |
| Country | United States | Hong Kong |
| Employees | N/A | N/A |
| Industry | Meat/Poultry/Fish | Medicinal Chemicals and Botanical Products |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.9B | 8.4B |
| IPO Year | 1987 | 2021 |
Fundamental Metrics
Financial Performance| Metric | PPC | RGC |
|---|---|---|
| Price | $39.01 | $13.27 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $47.00 | N/A |
| AVG Volume (30 Days) | ★ 1.2M | 139.3K |
| Earning Date | 10-29-2025 | 10-24-2025 |
| Dividend Yield | ★ 21.56% | N/A |
| EPS Growth | ★ 24.34 | N/A |
| EPS | ★ 5.16 | N/A |
| Revenue | ★ $18,351,780,000.00 | N/A |
| Revenue This Year | $3.98 | N/A |
| Revenue Next Year | $0.51 | N/A |
| P/E Ratio | $7.55 | ★ N/A |
| Revenue Growth | ★ 1.76 | N/A |
| 52 Week Low | $35.73 | $0.09 |
| 52 Week High | $57.16 | $83.60 |
Technical Indicators
Market Signals| Indicator | PPC | RGC |
|---|---|---|
| Relative Strength Index (RSI) | 58.90 | 49.04 |
| Support Level | $37.17 | $10.50 |
| Resistance Level | $39.16 | $14.18 |
| Average True Range (ATR) | 0.83 | 1.15 |
| MACD | 0.25 | 0.16 |
| Stochastic Oscillator | 76.69 | 76.36 |
Price Performance
Historical ComparisonAbout PPC Pilgrim's Pride Corporation
Pilgrim's Pride is the second-largest poultry producer in the US (59% of 2024 sales), the UK (29% including other European sales), and Mexico (12%). Its UK and European arm also includes pork operations from the 2019 acquisition of Tulip. Pilgrim's sells to chain restaurants, food processors, food distributors, and retail chains. Most of its US and Mexican sales come from fresh chicken, while prepared chicken and pork constitute most of its UK and European sales. JBS owns more than 80% of Pilgrim's Pride's outstanding shares, though it failed to acquire the remaining stake in 2021 after a special board committee deemed that JBS' offer undervalued Pilgrim's Pride.
About RGC Regencell Bioscience Holdings Limited
Regencell Bioscience Holdings Ltd is a bioscience company focusing on the research, development, and commercialization of TCM for the treatment of neurocognitive disorders and degenerations, specifically ADHD and ASD, and infectious diseases affecting people's immune systems.